Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China flag China · Delayed Price · Currency is CNY
11.38
-0.02 (-0.18%)
Apr 10, 2026, 3:04 PM CST

SHE:000590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
177.71177.29189.77235.42250.68
Trading Asset Securities
---25.1175.15
Cash & Short-Term Investments
177.71177.29189.77260.53325.83
Cash Growth
0.24%-6.58%-27.16%-20.04%-4.99%
Accounts Receivable
67.69103.15154.4117.16124.81
Other Receivables
16.1490.2860.5130.116
Receivables
83.83193.43214.91147.27130.82
Inventory
109.57124.78130.09118.2286.59
Prepaid Expenses
-2.32-0.030
Other Current Assets
7.762.174.793.0610.65
Total Current Assets
378.87499.99539.55529.11553.88
Property, Plant & Equipment
308.31312.66293.81289.75240.89
Long-Term Investments
23.0220.0320.91919
Goodwill
-13.2131.64137.14-
Other Intangible Assets
123.45131.06132.33157.44133.69
Long-Term Accounts Receivable
-3.095.057.42-
Long-Term Deferred Tax Assets
14.98.184.095.234.97
Long-Term Deferred Charges
7.46.293.322.931.82
Other Long-Term Assets
33.5218.9220.421913.57
Total Assets
889.471,0131,1511,167967.83
Accounts Payable
64.0773.2483.5564.0141.67
Accrued Expenses
35.6243.8846.6250.840.37
Short-Term Debt
-0.75-25.82-
Current Portion of Long-Term Debt
21.1611.011010.1-
Current Portion of Leases
-2.942.362.693
Current Income Taxes Payable
3.486.82.33.43.85
Current Unearned Revenue
36.1545.3350.1256.1353.42
Other Current Liabilities
40.8552.3153.8258.4544.68
Total Current Liabilities
201.33236.26248.77271.42186.98
Long-Term Debt
5082.228090-
Long-Term Leases
0.811.493.075.185.59
Long-Term Unearned Revenue
44.9843.9942.4444.3746.29
Long-Term Deferred Tax Liabilities
5.815.155.917.470.02
Other Long-Term Liabilities
37.0543.0742.7246.0946.62
Total Liabilities
339.98412.18422.92464.53285.5
Common Stock
239.47239.47239.47239.47239.47
Additional Paid-In Capital
473.95474.06474.06474.06474.06
Retained Earnings
-165.81-115.2910.18-15.06-33.21
Total Common Equity
547.61598.25723.72698.47680.32
Minority Interest
1.872.994.494.032
Shareholders' Equity
549.49601.23728.2702.5682.32
Total Liabilities & Equity
889.471,0131,1511,167967.83
Total Debt
71.9798.4295.43133.798.58
Net Cash (Debt)
105.7478.8794.34126.74317.24
Net Cash Growth
34.07%-16.40%-25.56%-60.05%-6.13%
Net Cash Per Share
0.440.330.390.531.32
Filing Date Shares Outstanding
239.38239.47239.47239.47239.47
Total Common Shares Outstanding
239.38239.47239.47239.47239.47
Working Capital
177.54263.73290.78257.69366.9
Book Value Per Share
2.292.503.022.922.84
Tangible Book Value
424.17453.98459.75403.89546.63
Tangible Book Value Per Share
1.771.901.921.692.28
Buildings
-267.95247.28243.93198.81
Machinery
-220.21197.31189.09174.95
Construction In Progress
-8.8123.8315.214.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.